0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Formoterol"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
EUR$3,800USDGBP
EUR$3,500USDGBP
EUR$3,500USDGBP
Symbicort - Product Thumbnail Image

Symbicort

  • Report
  • July 2018
  • 30 Pages
  • Global
From
EUR$10,000USDGBP
Fumarate De Formoterol - API Insight, 2022 - Product Thumbnail Image

Fumarate De Formoterol - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
EUR$129USDGBP
Loading Indicator

Formoterol is a long-acting beta-2 agonist (LABA) used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. Formoterol is typically used in combination with an inhaled corticosteroid (ICS) to provide long-term control of symptoms. It is also used as a rescue medication to provide quick relief from acute symptoms. Formoterol is available in both metered-dose inhalers (MDIs) and dry powder inhalers (DPIs). It is also available in combination with other drugs, such as budesonide and mometasone. Formoterol is generally well-tolerated, with few side effects. Formoterol is one of the most widely used drugs in the respiratory market. It is used to treat a variety of conditions, including asthma, COPD, and bronchospasm. It is also used as a rescue medication for acute symptoms. Some companies in the Formoterol market include GlaxoSmithKline, Merck, Novartis, and Boehringer Ingelheim. Show Less Read more